PF-4840154 is pyrimidine derivative discovered by Pfizer at its Sandwich, Kent research center. The compound is a potent, selective activator of both the human (EC50 = 23 nM) and rat (EC50 = 97 nM) TRPA1 channels. This compound elicits nociception in a mouse model through TRPA1 activation. PF-4840154 is used as a reference agonist of the TRPA1 channel for in-vitro High-throughput screening purposes, and is superior to allyl isothiocyanate for this use.
| Property | Value |
|---|---|
| dbpedia-owl:abstract |
|
| dbpedia-owl:iupacName |
|
| dbpedia-owl:thumbnail | |
| dbpprop:hasPhotoCollection | |
| dbpprop:imagefile |
|
| dbpprop:imagesize |
|
| dbpprop:iupacname |
|
| dbpprop:verifiedrevid |
|
| dbpprop:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| wdrs:describedby |
|
| http://www.w3.org/ns/prov#wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| is foaf:primaryTopic of |



